지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Background: ADRs (adverse drug reactions) are becoming a vital aspect of patient care and assessment. ADRs account for about 2% of all hospitalizations, according to the incidence rate. Medications with a narrow therapeutic index need ADR control rather than others. ADR research is required to determine the prevalence of ADRs in medical inpatients, estimate the impact of ADRs to hospital admissions, classify the types of ADRs found, identify possibly contributing risk factors, as well as estimate the costs of ADRs in terms of ADR-related excess stay in the hospital. For several years, theophylline has been used to treat asthma and chronic obstructive pulmonary disease (COPD). Theophylline-related adverse events (ADRs) were found to be 4.71 percent of the time, with nausea, anorexia (loss of appetite), and palpitation being the most common.
Objective: The main objective of the study was to study adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India.
Methodology: For an eight-month period, a prospective, descriptive, cross-sectional study was conducted in the pulmonary medicine department of a Tertiary care hospital in Srinagar, Jammu & Kashmir, India. ADRs that occurred in the ward were closely tracked, and the collected reports were analyzed for demographic profile, type of ADRs, ADR occurrence and drug causing ADR, severity assessment, and ADR management.
Results: During the study period, 420 patients" records were obtained from the pulmonary medicine department of a Tertiary care hospital. ADRs were registered in 60 of the patients. The demographics of ADR patients were analyzed, and it was discovered that the prevalence of ADR was highest in the age group of 50-59 years (21 out of 60) and lowest in the age group of <=19 years. The therapeutic drug groups most often involved in ADRs were investigated. The most common culprits among the medications are first-line TB drugs, which account for 21(35%) ADRs, corticosteroids, which account for 9 (15%) ADRs and other drugs used for different indications, such as ipratropium, furosemide, tramadol, and so on, which account for 30 (50%) ADRs. Hepatitis, loss of appetite, nausea, and vertigo were the most widely recorded ADRs in this study.
Conclusion: ADRs are more prevalent in the elderly, and first-line TB drugs are more often implicated. The majority of the reactions were moderate. As a result, early identification, assessment, and control of ADRs are critical for reducing patient harm and improving public health.
Objective: The main objective of the study was to study adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India.
Methodology: For an eight-month period, a prospective, descriptive, cross-sectional study was conducted in the pulmonary medicine department of a Tertiary care hospital in Srinagar, Jammu & Kashmir, India. ADRs that occurred in the ward were closely tracked, and the collected reports were analyzed for demographic profile, type of ADRs, ADR occurrence and drug causing ADR, severity assessment, and ADR management.
Results: During the study period, 420 patients" records were obtained from the pulmonary medicine department of a Tertiary care hospital. ADRs were registered in 60 of the patients. The demographics of ADR patients were analyzed, and it was discovered that the prevalence of ADR was highest in the age group of 50-59 years (21 out of 60) and lowest in the age group of <=19 years. The therapeutic drug groups most often involved in ADRs were investigated. The most common culprits among the medications are first-line TB drugs, which account for 21(35%) ADRs, corticosteroids, which account for 9 (15%) ADRs and other drugs used for different indications, such as ipratropium, furosemide, tramadol, and so on, which account for 30 (50%) ADRs. Hepatitis, loss of appetite, nausea, and vertigo were the most widely recorded ADRs in this study.
Conclusion: ADRs are more prevalent in the elderly, and first-line TB drugs are more often implicated. The majority of the reactions were moderate. As a result, early identification, assessment, and control of ADRs are critical for reducing patient harm and improving public health.
목차
ABSTRACT
INTRODUCTION
METHODOLOGY
RESULTS
DISCUSSION
CONCLUSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
단일 대학병원의 지역의약품안전센터에 보고된 소아청소년의 약물유해반응 분석
Allergy Asthma & Respiratory Diseases
2018 .01
-
단일기관에서 전산을 통해 수집된 자발적 소아 약물유해반응 보고사례의 분석
Allergy Asthma & Respiratory Diseases
2016 .01
-
Risk Factors Related to Serious Adverse Drug Reactions Reported through Electronic Submission during Hospitalization in Elderly Patients
Korean Journal of Family Medicine
2022 .03
-
한방의료기관에서 자발적 보고된 한약의 약물이상사례 분석
병원약사회지
2017 .01
-
1차 항결핵제 약물이상반응 현황: 단일기관 약물이상사례 보고사례 기반 분석
대한내과학회지
2021 .10
-
중동 호흡기 증후군 치료에 사용한 항바이러스제의 약물이상반응 발현양상 분석
병원약사회지
2017 .08
-
Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea
Journal of Korean Medical Science
2023 .02
-
L-asparaginase 약물 유해 반응 보고 분석
한국임상약학회지
2017 .01
-
중증피부과민반응에 대한 약물이상반응 보고자료의 분석
병원약사회지
2017 .01
-
자발적 보고자료를 이용한 노인의 약물유해반응 특성
대한내과학회지
2017 .06
-
텍스트마이닝을 이용한 약물유해반응 보고자료 분석
한국임상약학회지
2017 .01
-
Pharmacovigilance and Its Importance for Primary Health Care Professionals
Korean Journal of Family Medicine
2022 .09
-
EMR의 자발적 약물부작용보고 시스템을 이용한 한약약물유해반응 분석
대한한의학회지
2015 .03
-
Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System
Journal of Korean Medical Science
2022 .04
-
요오드화 조영제 부작용: 성분별 발생 빈도 비교
Allergy Asthma & Respiratory Diseases
2021 .01
-
Analysis of Adverse Drug Reactions Identified in Nursing Notes Using Reinforcement Learning
Healthcare Informatics Research
2020 .01
-
외과계 중환자실에서의 약물유해반응 탐색에 대한 방법론적 접근
병원약사회지
2017 .01
-
약물 유해 반응에 대한 간호사의 모니터링 실천에 관한 연구
간호행정학회지
2016 .01
-
만성 심부전 노인 환자에서 다약제 사용에 따른 위험성 평가
병원약사회지
2021 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-470-001310665